Drug details
Afinitor (everolimus tablets)
type of Antineoplastics mTOr Kinase Inhibitors
Afinitor (everolimus) is an antineoplastic agent (cancer medication) used to treat advanced kidney cancer, and is usually given after sorafenib (Nexavar) or sunitinib (Sutent) have been tried without successful treatment of symptoms.
This drug may have the following side effects:
- nausea,
- headache,
- vomiting,
- diarrhea,
- constipation,
- weight loss,
- itching or skin rash,
- acne,
- dry skin,
- decreased appetite,
- changes in taste or unusual taste in your mouth,
- nosebleeds,
- pain or sores in the mouth and throat,
- cold symptoms (stuffy nose, sneezing, sore throat),
- temporary hair loss, or
- pain in your arms and legs.
The following drugs are related to Afinitor, either as a replacement or used together:
- Krazati (adagrasib tablets)
- Proleukin (aldesleukin for injection)
- Rybrevant (amivantamab-vmjw for injection)
- Thymoglobulin (anti-thymocyte globulin (rabbit) intravenous administration)
- Azedra (iobenguane i 131 injection)
- Welireg (belzutifan tablets)
- Zirabev (bevacizumab-bvzr injection)
- Cabometyx (cabozantinib tablets)
- Libtayo (cemiplimab-rwlc injection)
- Cosela (trilaciclib for injection)
- Vizimpro (dacomitinib)
- Orserdu (elacestrant tablets)
- Elzonris (tagraxofusp-erzs injection)
- Pharmorubicin (epirubicin)
- Fotivda (tivozanib capsules)
- Fyarro (sirolimus protein-bound particles for injectable suspension)
- Sancuso (granisetron transdermal system)
- Herzuma (trastuzumab-pkrb for injection)
- Hyftor (sirolimus)
- Jaypirca (pirtobrutinib tablets)
- Vitrakvi (larotrectinib capsules)
- Lumakras (sotorasib tablets)
- Margenza (margetuximab-cmkb injection, for intravenous use)
- Poteligeo (mogamulizumab-kpkc injection)
- Nexavar (sorafenib)
- Ontruzant (trastuzumab-dttb for injection)
- Udenyca (pegfilgrastim-cbqv injection)
- Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf injection)
- Sutent (sunitinib malate)
- Torisel (temsirolimus injection)
- Tepmetko (tepotinib tablets)